Ticker: VRTX

Company: VERTEX PHARMACEUTICALS INC / MA

Person: Reshma Kewalramani, director, officer

Transaction date: Aug. 6, 2025

Reporting date: Aug. 7, 2025

Average share price: 389.57677

Bought 10000.0 shares for 3895767.7